Tuesday, April 17, 2012

Merz Pharma Canada, Ltd. Announces Health Canada Approval of XEOMIN® COSMETIC (Clostridium Botulinum Neurotoxin Type A (150kD), free from complexing proteins) for the Temporary Improvement in the Appearance of Moderate to Severe Glabellar Lines

Merz Pharma Canada, Ltd. Announces Health Canada Approval of XEOMIN® COSMETIC (Clostridium Botulinum Neurotoxin Type A (150kD), free from complexing proteins) for the Temporary Improvement in the Appearance of Moderate to Severe Glabellar Lines
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)